Fewer lab animals, better drugs: This startup wants to fix how experiments get designed

ModernVivo co-founders Colin Small (left) and Ian Levine (right). Seattle-based ModernVivo is using AI to help scientists design preclinical studies for drug discovery. The goal: better experiments that are also faster, cheaper and less reliant on animals.